FDLI/FDA Conference In Brief

Food prioritized in FDA Globalization Act: The House Energy and Commerce Committee will break out food safety provisions from the FDA Globalization Act, H.R. 759, as a separate bill since Chairman Henry Waxman and others in Congress have made securing the food supply a top priority. Speaking at the Food and Drug Law Institute/FDA conference in Washington April 23, Energy and Commerce majority counsel Rachel Sher explained the committee is attempting to squeeze in work on food safety with other top legislative priorities, namely health care reform and carbon emission cap-and-trade. In addition to using FDAGA "as a foundation to draft a strong food safety bill," as Waxman, D-Calif., has suggested, Sher said the chairman "intends to look closely" at Rep. Rosa DeLauro's Food Safety Modernization Act, H.R. 875, in which the Connecticut Democrat proposes placing food safety in a new agency outside FDA. Sher said Waxman is seeking additional authorities for FDA, including access to manufacturer records and mandatory recall. While Waxman would prefer not to resort to user fees to fund the agency's food safety initiatives, "the need for a stronger food program is so dire that if it appears the monies we're able to come up with through the appropriations process are inadequate, he believes we must look to regulated industry to help," Sher said. The committee will address drug, device and cosmetic provisions of FDAGA after food safety, Sher added. Michigan Democrat John Dingell introduced FDAGA in January (1"The Tan Sheet" March 16, 2009, p. 16)

More from Archive

Ocaliva: Still No Clarity On Why EU Court Opposed Revocation Of Approval

 

Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.

Final Chance To Have Your Say: Take Our Reader Survey This Week

 
• By 

This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.

Shape Our Content: Take The Reader Survey

 
• By 

We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.

Brazil Pilots Digital Drug Pack Inserts

 

A new pilot aims to take Brazil closer to ‘digital transformation.’

More from Pink Sheet

US FDA Commissioner Rejected Some Proposed Reorg Plans

 
• By 

FDA Commissioner Martin Makary said in an interview that he will use the current structure to reform the agency. He also plans to address employee morale.

How States And Courts Could Insulate America From An Anti-Vaccine Executive Branch

 

The mood at the World Vaccines Congress in Washington, D.C. was bleak given Robert F. Kennedy Jr.’s rise to lead the Trump Administration’s Health and Human Services Department, but vaccine lawyers offered an optimistic outlook and ideas for countering his vaccine agenda.

PharmaMar Seeks EU Fast-Track Status For ‘Practice-Changing’ ES-SCLC Therapy

 

PharmaMar, which wants to use the Jazz Pharmaceuticals-partnered drug, lurbinectedin, in combination with Roche’s Tecentriq for treating extensive-stage small cell lung cancer, is one of two companies that this month sought an accelerated assessment of their planned EU marketing applications.